Emprise Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Hold
244
0.11% 83
2026
Q1
$224K Hold
244
0.09% 97
2025
Q4
$262K Sell
244
-100
-29% -$95.6K 0.11% 91
2025
Q3
$262K Hold
344
0.11% 90
2025
Q2
$268K Sell
344
-204
-37% -$159K 0.13% 84
2025
Q1
$453K Sell
548
-28
-5% -$23.3K 0.24% 65
2024
Q4
$445K Sell
576
-28
-5% -$23.2K 0.25% 68
2024
Q3
$535K Sell
604
-456
-43% -$410K 0.31% 61
2024
Q2
$960K Sell
1,060
-24
-2% -$19.2K 0.59% 41
2024
Q1
$843K Buy
+1,084
New +$771K 0.57% 45

Other funds holding LLY

Emprise Bank's LLY Position: Q2 2026 in Review

Emprise Bank held its Eli Lilly (LLY) position steady in Q2 2026 at 244 shares worth $293K. The position accounts for 0.11% of the portfolio, ranked #83.

Emprise Bank first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $960K in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Emprise Bank held 244 shares of Eli Lilly worth $293K as of Q2 2026.
  • Emprise Bank left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.11% of Emprise Bank's portfolio in Q2 2026, its #83 holding.
  • Emprise Bank first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Emprise Bank's Eli Lilly position peaked at $960K in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Emprise Bank's 13F filing for Q2 2026, filed 7 Jul 2026.